These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21150845)

  • 1. Treatment of pathological gambling with naltrexone pharmacotherapy and brief intervention: a pilot study.
    Lahti T; Halme JT; Pankakoski M; Sinclair D; Alho H
    Psychopharmacol Bull; 2010; 43(3):35-44. PubMed ID: 21150845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological gambling: comorbid psychiatric diagnoses in patients and their families.
    Dannon PN; Lowengrub K; Aizer A; Kotler M
    Isr J Psychiatry Relat Sci; 2006; 43(2):88-92. PubMed ID: 16910370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomised, Double-Blind, Placebo-Controlled Trial of As-Needed Naltrexone in the Treatment of Pathological Gambling.
    Kovanen L; Basnet S; Castrén S; Pankakoski M; Saarikoski ST; Partonen T; Alho H; Lahti T
    Eur Addict Res; 2016; 22(2):70-9. PubMed ID: 26339899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers.
    Grant JE; Odlaug BL; Chamberlain SR; Potenza MN; Schreiber LR; Donahue CB; Kim SW
    J Clin Psychiatry; 2014 Jan; 75(1):39-45. PubMed ID: 24345329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisocial personality disorder is associated with increased severity of gambling, medical, drug and psychiatric problems among treatment-seeking pathological gamblers.
    Pietrzak RH; Petry NM
    Addiction; 2005 Aug; 100(8):1183-93. PubMed ID: 16042649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study.
    Dannon PN; Lowengrub K; Musin E; Gonopolsky Y; Kotler M
    J Clin Psychopharmacol; 2007 Dec; 27(6):620-4. PubMed ID: 18004130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
    Grant JE; Potenza MN; Hollander E; Cunningham-Williams R; Nurminen T; Smits G; Kallio A
    Am J Psychiatry; 2006 Feb; 163(2):303-12. PubMed ID: 16449486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity of gambling is associated with severity of depressive symptoms in pathological gamblers.
    Rømer Thomsen K; Callesen MB; Linnet J; Kringelbach ML; Møller A
    Behav Pharmacol; 2009 Sep; 20(5-6):527-36. PubMed ID: 19654506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study.
    Grant JE; Kim SW; Odlaug BL
    Biol Psychiatry; 2007 Sep; 62(6):652-7. PubMed ID: 17445781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study.
    Black DW; Arndt S; Coryell WH; Argo T; Forbush KT; Shaw MC; Perry P; Allen J
    J Clin Psychopharmacol; 2007 Apr; 27(2):143-50. PubMed ID: 17414236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of a single session motivational intervention for concerned gamblers.
    Diskin KM; Hodgins DC
    Behav Res Ther; 2009 May; 47(5):382-8. PubMed ID: 19249015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating gambling disorder with as needed administration of intranasal naloxone: a pilot study to evaluate acceptability, feasibility and outcomes.
    Castrén S; Mäkelä N; Haikola J; Salonen AH; Crystal R; Scheinin M; Alho H
    BMJ Open; 2019 Aug; 9(8):e023728. PubMed ID: 31439593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone in patients with bipolar disorder and alcohol dependence.
    Brown ES; Beard L; Dobbs L; Rush AJ
    Depress Anxiety; 2006; 23(8):492-5. PubMed ID: 16841344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological gambling and obsessive compulsive disorder among methadone maintenance treatment patients.
    Peles E; Schreiber S; Adelson M
    J Addict Dis; 2009 Jul; 28(3):199-207. PubMed ID: 20155588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study.
    Dannon PN; Lowengrub K; Musin E; Gonopolski Y; Kotler M
    J Clin Psychopharmacol; 2005 Dec; 25(6):593-6. PubMed ID: 16282845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of a cognitive-behavioral intervention for pathological gambling: a country-wide study.
    Pasche SC; Sinclair H; Collins P; Pretorius A; Grant JE; Stein DJ
    Ann Clin Psychiatry; 2013 Nov; 25(4):250-6. PubMed ID: 24199214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label trial of escitalopram in the treatment of pathological gambling.
    Black DW; Shaw M; Forbush KT; Allen J
    Clin Neuropharmacol; 2007; 30(4):206-12. PubMed ID: 17762317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid antagonist naltrexone for the treatment of pathological gambling in Parkinson disease.
    Bosco D; Plastino M; Colica C; Bosco F; Arianna S; Vecchio A; Galati F; Cristiano D; Consoli A; Consoli D
    Clin Neuropharmacol; 2012; 35(3):118-20. PubMed ID: 22426027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A latent class analysis of DSM-IV pathological gambling criteria in a nationally representative British sample.
    McBride O; Adamson G; Shevlin M
    Psychiatry Res; 2010 Jul; 178(2):401-7. PubMed ID: 20488550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concordance between the SOGS-RA and the DSM-IV criteria for pathological gambling among youth.
    Ladouceur R; Ferland F; Poulin C; Vitaro F; Wiebe J
    Psychol Addict Behav; 2005 Sep; 19(3):271-6. PubMed ID: 16187805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.